Wiegand Uwe K H, Bode Frank, Bonnemeier Hendrik, Eberhard Frank, Schlei Monika, Peters Werner
University of Lübeck, Medizinische Klinik II, Lübeck, Germany.
Pacing Clin Electrophysiol. 2003 Oct;26(10):1961-9. doi: 10.1046/j.1460-9592.2003.00303.x.
A higher incidence of pacemaker related complications has been reported in DDD systems as compared to VVI devices. The implantation of single lead VDD pacemakers might reduce the complication rate of physiological pacing in patients with AV block. In a retrospective study, the data records of 1,214 consecutive patients with pacemaker implantation for AV block between 1990 and 2001 (VVI 36.5%, DDD 32.9%, VDD 30.6%) were analyzed. Complications requiring surgical interventions were compared during a follow-up period of 64 +/- 31 months. Operation and fluoroscopic times were longer in DDD pacemaker implantation compared to VDD and VVI devices:58 +/- 23 versus 39 +/- 10 and 37 +/- 13 minutes (P<0.001), 9.2 +/- 5.2 versus 4.1 +/- 2.4 and 3.5 +/- 2.3 minutes, respectively. Differences remained significant after correction for covariates. In a multivariate Cox regression model, the corrected complication hazard of a DDD pacemaker implantation was increased by 3.9 (1.4-11.3) compared to VVI and increased by 2.3 (1.1-4.5) compared to VDD pacing. Higher complication rates in DDD pacing were mainly due to a higher incidence of early reoperation for atrial lead dysfunction, whereas the long-term complication rate was not different from VDD or VVI pacing. Early and long-term complication rates did not differ between VDD and VVI pacemaker systems. In conclusion, operation time and complication rates of physiological pacing are reduced by VDD pacemaker implantation achieving values comparable to VVI pacing. Thus, single lead VDD pacing can be recommended for patients with AV block.
与VVI装置相比,DDD系统中起搏器相关并发症的发生率更高。单导联VDD起搏器的植入可能会降低房室传导阻滞患者生理性起搏的并发症发生率。在一项回顾性研究中,分析了1990年至2001年间1214例因房室传导阻滞植入起搏器的连续患者的数据记录(VVI占36.5%,DDD占32.9%,VDD占30.6%)。在64±31个月的随访期内比较了需要手术干预的并发症情况。与VDD和VVI装置相比,DDD起搏器植入的手术时间和透视时间更长:分别为58±23分钟、39±10分钟和37±13分钟(P<0.001),9.2±5.2分钟、4.1±2.4分钟和3.5±2.3分钟。校正协变量后差异仍然显著。在多变量Cox回归模型中,与VVI相比,DDD起搏器植入的校正并发症风险增加了3.9(1.4 - 11.3),与VDD起搏相比增加了2.3(1.1 - 4.5)。DDD起搏较高的并发症发生率主要是由于心房导线功能障碍早期再次手术的发生率较高,而长期并发症发生率与VDD或VVI起搏并无差异。VDD和VVI起搏器系统的早期和长期并发症发生率没有差异。总之,VDD起搏器植入可减少生理性起搏的手术时间和并发症发生率,达到与VVI起搏相当的值。因此,对于房室传导阻滞患者,可推荐单导联VDD起搏。